Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical Device Company Intelligence Reports are currently available. In 2005, a range of intraocular lenses (IOLs) and consumables were added to the company's product line through the acquisition of Ioltech. The company has also recently expanded its portfolio further with the acquisition of Carl Zeiss Surgical from Carl Zeiss. Carl Zeiss Surgical is the world's leading provider of surgical microscopes and adds visualisation solutions for ophthalmic, neuro and ENT surgery to the CZM line.

CZM is based in Jena, Germany, with subsidiaries in Pirmasens, Germany, the US, Japan and France. Carl Zeiss, a leading manufacturer of optical and opto-electronics technology, owns 65% of CZM and the remaining 35% of shares are in free float.

Carl Zeiss Surgical GmbH is based in Oberkochen, Germany, and offers surgical microscopes for all disciplines of microsurgery, as well as visualisation and documentation systems. It claims to have enjoyed market leadership in its field for over 50 years, with two out of every three microsurgeons worldwide using the company's surgical microscopes.